TP53 and p21 (CDKN1A) polymorphisms and the risk of systemic lupus erythematosus.
Adv Rheumatol
; 63(1): 43, 2023 08 21.
Article
in En
| MEDLINE
| ID: mdl-37605254
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Tumor Suppressor Protein p53
/
Cyclin-Dependent Kinase Inhibitor p21
/
Lupus Erythematosus, Systemic
Type of study:
Etiology_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
Language:
En
Journal:
Adv Rheumatol
Year:
2023
Document type:
Article
Affiliation country:
Brasil
Country of publication:
Reino Unido